# ![@iamnakaz2023 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1673563769887391744.png) @iamnakaz2023 NAKA

NAKA posts on X about for the, $msd, $pfe, $mrk the most. They currently have [-----] followers and [--] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::1673563769887391744/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1673563769887391744/c:line/m:interactions.svg)

- [--] Months [-----] +240%
- [--] Year [-----] +674,500%

### Mentions: [--] [#](/creator/twitter::1673563769887391744/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1673563769887391744/c:line/m:posts_active.svg)


### Followers: [-----] [#](/creator/twitter::1673563769887391744/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1673563769887391744/c:line/m:followers.svg)

- [--] Months [-----] +7.30%
- [--] Year [-----] +73%

### CreatorRank: [---------] [#](/creator/twitter::1673563769887391744/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1673563769887391744/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [countries](/list/countries)  [technology brands](/list/technology-brands)  [celebrities](/list/celebrities)  [finance](/list/finance)  [cryptocurrencies](/list/cryptocurrencies) 

**Social topic influence**
[for the](/topic/for-the), [$msd](/topic/$msd) #1, [$pfe](/topic/$pfe) #165, [$mrk](/topic/$mrk) #20, [target](/topic/target), [just a](/topic/just-a), [$100b](/topic/$100b) #52, [japan](/topic/japan), [pearl harbor](/topic/pearl-harbor), [iran](/topic/iran)

**Top accounts mentioned or mentioned by**
[@xprize](/creator/undefined) [@realdonaldtrump](/creator/undefined) [@kabumandoctor](/creator/undefined) [@abema](/creator/undefined) [@wallstreetpurio](/creator/undefined) [@proselector123](/creator/undefined) [@elonmusk](/creator/undefined)

**Top assets mentioned**
[Pfizer, Inc. (PFE)](/topic/$pfe) [Merck & Co., Inc. (MRK)](/topic/$mrk) [ROGin AI (ROG)](/topic/$rog) [NorthWestern Corporation (NWE)](/topic/$nwe)
### Top Social Posts
Top posts by engagements in the last [--] hours

"IR ASH  [---] ASH"  
[X Link](https://x.com/iamnakaz2023/status/1726462644390105585)  2023-11-20T04:49Z [---] followers, [---] engagements


"@kabumandoctor"  
[X Link](https://x.com/iamnakaz2023/status/1731239585815101597)  2023-12-03T09:10Z [---] followers, [--] engagements


"3760  [----]   https://t.co/Mt3oztvnD6 [----]   https://t.co/Mt3oztvnD6"  
[X Link](https://x.com/iamnakaz2023/status/1742770520373039511)  2024-01-04T04:50Z [---] followers, [---] engagements


"3760   @ABEMA https://t.co/42aheGbyZ0 # # # # # # # # NA:# @ABEMA https://t.co/42aheGbyZ0 # # # # # # # # NA:#"  
[X Link](https://x.com/anyuser/status/1743408541720002915)  2024-01-05T23:06Z [--] followers, [--] engagements


"3760    [----] [--] PR [----] [--] PR"  
[X Link](https://x.com/iamnakaz2023/status/1744318563102462379)  2024-01-08T11:22Z [---] followers, [---] engagements


"3760  [--------] [--] [--] 1/15 [----]    3760"  
[X Link](https://x.com/anyuser/status/1744323879915676035)  2024-01-08T11:43Z [--] followers, [---] engagements


"1600 TAKARA2483(60) [--] [----] [---------] https://t.co/bw9vNPCgdF [--] [----] [---------] https://t.co/bw9vNPCgdF"  
[X Link](https://x.com/iamnakaz2023/status/1747485229160464740)  2024-01-17T05:05Z [---] followers, [---] engagements


"JTEC [----] 1319"  
[X Link](https://x.com/iamnakaz2023/status/1748119998361657799)  2024-01-18T23:07Z [---] followers, [--] engagements


"3446 JTEC 19"  
[X Link](https://x.com/iamnakaz2023/status/1748121645372576092)  2024-01-18T23:14Z [---] followers, [--] engagements


"@WALLSTREETpurio FPoS"  
[X Link](https://x.com/iamnakaz2023/status/1751411678955409628)  2024-01-28T01:07Z [---] followers, [--] engagements


"3810 2023.01.23IR 2"  
[X Link](https://x.com/iamnakaz2023/status/1752122020203311155)  2024-01-30T00:10Z [---] followers, [--] engagements


"3810  [-------] SEC 2023.12.27 w X"  
[X Link](https://x.com/anyuser/status/1752207422909984874)  2024-01-30T05:49Z [--] followers, [--] engagements


"1SEC3 [--------] 2"  
[X Link](https://x.com/iamnakaz2023/status/1752216417162985938)  2024-01-30T06:25Z [---] followers, [--] engagements


"@proselector123"  
[X Link](https://x.com/anyuser/status/1752546754497753525)  2024-01-31T04:18Z [--] followers, [--] engagements


"5591 AVILEN AIIPOPER PTS (2024)8600"  
[X Link](https://x.com/iamnakaz2023/status/1757690996824138012)  2024-02-14T08:59Z [---] followers, [--] engagements


"5591 AVILEN NVIDIA"  
[X Link](https://x.com/iamnakaz2023/status/1757924754206642601)  2024-02-15T00:28Z [---] followers, [--] engagements


"5591 AVILEN nVIDIAAI"  
[X Link](https://x.com/iamnakaz2023/status/1757926144702370297)  2024-02-15T00:33Z [---] followers, [--] engagements


"3416 Getty images AINVIDIAGenerative AI by Getty images powered by NVIDIA20241 AIPIXTA"  
[X Link](https://x.com/iamnakaz2023/status/1761911397188063588)  2024-02-26T00:29Z [---] followers, [--] engagements


"Mr. Elon Musk should move to acquire Astroscale HD as soon as possible in order to speed up space development. This company's RPO technology is also essential to U.S. space defense and SpaceX operations. Japan has left these companies alone with less than $1 billion and the project is stalled by a government that lacks judgment. ElonMusk SpaceX Trump"  
[X Link](https://x.com/iamnakaz2023/status/1896392492209307844)  2025-03-03T02:49Z [---] followers, [---] engagements


"Americans have been saying that Pearl Harbor was cowardly and yet they launched a surprise attack on Iran. It would be better for the world if both America and Americans perished"  
[X Link](https://x.com/iamnakaz2023/status/1936632504980836696)  2025-06-22T03:49Z [----] followers, [---] engagements


"@realDonaldTrump Americans have been saying that Pearl Harbor was cowardly and yet they launched a surprise attack on Iran. It would be better for the world if both America and Americans perished"  
[X Link](https://x.com/iamnakaz2023/status/1936638485613687290)  2025-06-22T04:12Z [----] followers, [---] engagements


"@realDonaldTrump Americans have been saying that Pearl Harbor was cowardly and yet they launched a surprise attack on Iran. It would be better for the world if both America and Americans perished"  
[X Link](https://x.com/iamnakaz2023/status/1936638960744431848)  2025-06-22T04:14Z [----] followers, [---] engagements


"https://jp.cointelegraph.com/news/okx-joins-paxos-usdg-network-stablecoin https://jp.cointelegraph.com/news/okx-joins-paxos-usdg-network-stablecoin"  
[X Link](https://x.com/iamnakaz2023/status/1944987701792350682)  2025-07-15T05:09Z [----] followers, [---] engagements


"Renascience (TSE Code: 4889) World's First Publication of Paper on the Anti-Aging Effects of PAI-1 Inhibitor RS5614: Reversing Vascular Aging In a collaborative study with Northwestern University (USA) and Tohoku University Graduate School of Medicine (Japan) we have demonstrated that our PAI-1 inhibitor RS5614 may reverse vascular aging including arteriosclerosis. The paper was published in The Journal of Clinical Investigation on September [--] [----]. https://www.jci.org/articles/view/196714 https://www.jci.org/articles/view/196714"  
[X Link](https://x.com/iamnakaz2023/status/1973256288881745982)  2025-10-01T05:18Z [----] followers, [---] engagements


"@elonmusk Rena Science Co. Ltd. (TSE code: 4889) A Japanese company. Stock market capitalization $150 million Strengthen cooperation with the Saudi Arabian government. Longevity/longevity-related drug RS5614 CML (market size: [--] trillion) melanoma (market size: [--] trillion) longevity-related vascular rejuvenation etc. All RS5614. RS5441 is currently being developed by Aerion Therapeutics as ET-02 a hair growth agent that surpasses minoxidil. Phase [--] of RS5614 ends in March 2026"  
[X Link](https://x.com/iamnakaz2023/status/1973631123042504738)  2025-10-02T06:08Z [----] followers, [--] engagements


"Overseas Investment Information Japan: TSE Code [----] RenaScience We announced strengthening our collaboration with the Saudi Arabian government (MISA SAIP SFDA etc.) and signed a memorandum of understanding (MOU) with KAIMRC the Saudi Arabian government's medical research institute covering the following: (1) Clinical development of the PAI-1 inhibitor RS5614: Clinical development in Saudi Arabia as a cancer treatment and anti-aging/longevity treatment (2) Participation in the XPRIZE Healthspan collaborative research team: Participation in clinical trials at XPRIZE Healthspan and conducting"  
[X Link](https://x.com/iamnakaz2023/status/1975754738135409027)  2025-10-08T02:46Z [----] followers, [---] engagements


"2026Xprize HealthspanTOP10RS5614CML MOUAI  [---] TOP10  [---] TOP10"  
[X Link](https://x.com/anyuser/status/2021024060348788811)  2026-02-10T00:50Z [----] followers, [---] engagements


"RS5614 [--]. Merck & Co. (MSD): A "Booster" to Defend the Keytruda Fortress For Merck the upcoming patent cliff for Keytruda around [----] is less of a "cliff" and more of a "massive waterfall." Their interest in RS5614 transcends simple combination therapy. The Key to Overcoming Resistance (TME Improvement): One major reason Keytruda fails is the deterioration of the Tumor Microenvironment (TME). By inhibiting PAI-1 RS5614 breaks down the "barrier" created by cancer cells effectively ushering T-cells into the tumor. The "Subcutaneous + Oral" Combination: Merck is aggressively developing a"  
[X Link](https://x.com/anyuser/status/2022189936259023119)  2026-02-13T06:03Z [----] followers, [----] engagements


"$MSD $PFE $ROG 🚨 The next massive M&A target in Biotech Japans Renascience (4889.T) is sitting on a goldmine: RS5614. Why Big Pharma is circling: [--] Merck ($MRK): The perfect "booster" for #Keytruda to overcome the [----] patent cliff. [--] Pfizer ($PFE): A game-changing #Senolytic platform for aging. [--] Roche: Precision medicine paired with PAI-1 biomarkers. Plus they are semi-finalists in the $101M @XPRIZE Healthspan (backed by Elon Musk). A small-cap with multi-bagger potential as the "Geroscience" race heats up. 🚀 #Biotech #Longevity #StockMarket #Investment #SmallCap"  
[X Link](https://x.com/iamnakaz2023/status/2022192960100782404)  2026-02-13T06:15Z [----] followers, [---] engagements


"Is this the "Holy Grail" of Longevity 🧬 Renascience (4889.T) just hit the Top [--] in the $101M XPRIZE Healthspan competition. 🏆 Their PAI-1 inhibitor (RS5614) isn't just a drug; its a platform: ✅ Reverses vascular aging ✅ Boosts Immuno-oncology (Keytruda's savior) ✅ Safe Oral small molecule When a tiny Japanese biotech holds the key to the $100B cancer & aging market you don't wait for the newsyou watch the chart. 📈 @XPRIZE #Healthspan #Longevity #Biohacking #ElonMusk #StockAlert $MRK $PFE https://twitter.com/i/web/status/2022193141961658584"  
[X Link](https://x.com/anyuser/status/2022193141961658584)  2026-02-13T06:16Z [----] followers, [---] engagements


"Saudi Arabia is now the global hub for the future of #Longevity. Huge news from Riyadh: Japans Renascience (4889.T) has signed a definitive Clinical Trial Agreement (CTA) with KAIMRC (King Abdullah International Medical Research Center). 🧪✨ Why this is a 10x opportunity: 🔹 State-Backed: Validated by the Saudi governments top medical authority. 🔹 XPRIZE Finalist: A top contender in the $101M @XPRIZE Healthspan (co-titled by Saudis Hevolution Foundation). 🔹 Big Pharma Target: RS5614 is the "Holy Grail" for oncology ($MRK) and aging ($PFE). The bridge between Tokyo and Riyadh is creating the"  
[X Link](https://x.com/anyuser/status/2022195939050717454)  2026-02-13T06:27Z [----] followers, [---] engagements


"PAI-1 inhibition is the frontier of #Immunotherapy. RS5614 by Renascience (4889.T) is the ONLY oral PAI-1 inhibitor in clinical stages. The strategic value: 🔹 TME Reprogramming: Converts "Cold" tumors to "Hot." 🔹 Synergy: Essential for $MRK to defend Keytruda via combo-therapy. 🔹 Senolytics: Suppresses SASP to extend healthy life. Selected for the XPRIZE Healthspan Semi-finals. Huge valuation gap vs Western peers. The Big Pharma bidding war is inevitable. 💎 #Oncology #Geroscience #BiotechStocks #Alpha #NBI $XBI https://twitter.com/i/web/status/2022193596833935376"  
[X Link](https://x.com/anyuser/status/2022193596833935376)  2026-02-13T06:18Z [----] followers, [---] engagements


"$MSD $PFE 🚨 Is this the most undervalued Biotech in the world 🚨 Japans Renascience (4889.T) is flashing a massive "BUY" signal. 🧬💹 The Valuation Gap is Insane:🔹 Market Cap: Approx. $30M - $50M (Micro-cap) 🔹 Target Market: $100B+ (Oncology Aging CML Kidney Disease) This isn't just a "drug"its a PAI-1 platform that Big Pharma needs to survive. The Catalyst: CML Phase [--] Near Completion 🏁 The Phase [--] trial for Chronic Myeloid Leukemia (CML) is in its final stretch. ✅ Data so far: DMR (Deep Molecular Response) rate of 33.3% vs 8-12% (standard care). ✅ Goal: A complete cure allowing patients"  
[X Link](https://x.com/anyuser/status/2022196725386224118)  2026-02-13T06:30Z [----] followers, [---] engagements


"$MSD $PFE 🚨 Is this the most undervalued Biotech in the world 🚨 Japans Renascience (4889.T) is flashing a massive "BUY" signal. 🧬💹 The Valuation Gap is Insane:🔹 Market Cap: Approx. $30M - $50M (Micro-cap) 🔹 Target Market: $100B+ (Oncology Aging CML Kidney Disease) This isn't just a "drug"its a PAI-1 platform that Big Pharma needs to survive. The Catalyst: CML Phase [--] Near Completion 🏁 The Phase [--] trial for Chronic Myeloid Leukemia (CML) is in its final stretch. ✅ Data so far: DMR (Deep Molecular Response) rate of 33.3% vs 8-12% (standard care). ✅ Goal: A complete cure allowing patients"  
[X Link](https://x.com/anyuser/status/2022196725386224118)  2026-02-13T06:30Z [----] followers, [---] engagements


"Saudi Arabia is now the global hub for the future of #Longevity. Huge news from Riyadh: Japans Renascience (4889.T) has signed a definitive Clinical Trial Agreement (CTA) with KAIMRC (King Abdullah International Medical Research Center). 🧪✨ Why this is a 10x opportunity: 🔹 State-Backed: Validated by the Saudi governments top medical authority. 🔹 XPRIZE Finalist: A top contender in the $101M @XPRIZE Healthspan (co-titled by Saudis Hevolution Foundation). 🔹 Big Pharma Target: RS5614 is the "Holy Grail" for oncology ($MRK) and aging ($PFE). The bridge between Tokyo and Riyadh is creating the"  
[X Link](https://x.com/anyuser/status/2022195939050717454)  2026-02-13T06:27Z [----] followers, [---] engagements


"PAI-1 inhibition is the frontier of #Immunotherapy. RS5614 by Renascience (4889.T) is the ONLY oral PAI-1 inhibitor in clinical stages. The strategic value: 🔹 TME Reprogramming: Converts "Cold" tumors to "Hot." 🔹 Synergy: Essential for $MRK to defend Keytruda via combo-therapy. 🔹 Senolytics: Suppresses SASP to extend healthy life. Selected for the XPRIZE Healthspan Semi-finals. Huge valuation gap vs Western peers. The Big Pharma bidding war is inevitable. 💎 #Oncology #Geroscience #BiotechStocks #Alpha #NBI $XBI https://twitter.com/i/web/status/2022193596833935376"  
[X Link](https://x.com/anyuser/status/2022193596833935376)  2026-02-13T06:18Z [----] followers, [---] engagements


"Is this the "Holy Grail" of Longevity 🧬 Renascience (4889.T) just hit the Top [--] in the $101M XPRIZE Healthspan competition. 🏆 Their PAI-1 inhibitor (RS5614) isn't just a drug; its a platform: ✅ Reverses vascular aging ✅ Boosts Immuno-oncology (Keytruda's savior) ✅ Safe Oral small molecule When a tiny Japanese biotech holds the key to the $100B cancer & aging market you don't wait for the newsyou watch the chart. 📈 @XPRIZE #Healthspan #Longevity #Biohacking #ElonMusk #StockAlert $MRK $PFE https://twitter.com/i/web/status/2022193141961658584"  
[X Link](https://x.com/anyuser/status/2022193141961658584)  2026-02-13T06:16Z [----] followers, [---] engagements


"$MSD $PFE $ROG 🚨 The next massive M&A target in Biotech Japans Renascience (4889.T) is sitting on a goldmine: RS5614. Why Big Pharma is circling: [--] Merck ($MRK): The perfect "booster" for #Keytruda to overcome the [----] patent cliff. [--] Pfizer ($PFE): A game-changing #Senolytic platform for aging. [--] Roche: Precision medicine paired with PAI-1 biomarkers. Plus they are semi-finalists in the $101M @XPRIZE Healthspan (backed by Elon Musk). A small-cap with multi-bagger potential as the "Geroscience" race heats up. 🚀 #Biotech #Longevity #StockMarket #Investment #SmallCap"  
[X Link](https://x.com/iamnakaz2023/status/2022192960100782404)  2026-02-13T06:15Z [----] followers, [---] engagements


"RS5614 [--]. Merck & Co. (MSD): A "Booster" to Defend the Keytruda Fortress For Merck the upcoming patent cliff for Keytruda around [----] is less of a "cliff" and more of a "massive waterfall." Their interest in RS5614 transcends simple combination therapy. The Key to Overcoming Resistance (TME Improvement): One major reason Keytruda fails is the deterioration of the Tumor Microenvironment (TME). By inhibiting PAI-1 RS5614 breaks down the "barrier" created by cancer cells effectively ushering T-cells into the tumor. The "Subcutaneous + Oral" Combination: Merck is aggressively developing a"  
[X Link](https://x.com/anyuser/status/2022189936259023119)  2026-02-13T06:03Z [----] followers, [----] engagements


"XPRIZE HealthspanMOU PIF [--]. Renascience Inc.-  : KAIMRC : 202510MOU20262XPRIZE**CTA**PAI-1RS5614 [--]. Precision Health Alliance : : [--]. [----] XPRIZE : Aeovian PharmaceuticalsBMOU"  
[X Link](https://x.com/anyuser/status/2022160446548246749)  2026-02-13T04:06Z [----] followers, [----] engagements


"RS5614: Overcoming PD-1 Inhibitor Resistance RS5614 developed by Renascience Inc. is an oral PAI-1 inhibitor designed to dismantle the "shield" cancer cells use to evade the immune system. A major challenge with PD-1 inhibitors like Opdivo and Keytruda is that cancer cells eventually produce excessive PAI-1 creating an immunosuppressive barrier that prevents T-cells from attacking the tumor. This process leads to acquired drug resistance. RS5614 overcomes this by blocking PAI-1 effectively stripping away the tumor's protection and restoring an environment where the immune system can re-engage"  
[X Link](https://x.com/anyuser/status/2021768477166776392)  2026-02-12T02:09Z [----] followers, [---] engagements


"RS5614 [-----] OTC 10"  
[X Link](https://x.com/anyuser/status/2021026139775565890)  2026-02-10T00:59Z [----] followers, [---] engagements


"2026Xprize HealthspanTOP10RS5614CML MOUAI  [---] TOP10  [---] TOP10"  
[X Link](https://x.com/anyuser/status/2021024060348788811)  2026-02-10T00:50Z [----] followers, [---] engagements


"P3RS5614 ET-02 P3OTCRS5614 https://www.reddit.com/r/covidlonghaulers/comments/1oyezvm/comment/np5rtp8/ https://www.reddit.com/r/covidlonghaulers/comments/1oyezvm/comment/np5rtp8/"  
[X Link](https://x.com/anyuser/status/2017133679294730704)  2026-01-30T07:12Z [----] followers, [----] engagements


"1. KAIMRC [--]. XPRIZE Healthspan [--]. KAIMRC [--]. XPRIZE Healthspan"  
[X Link](https://x.com/anyuser/status/2021015326171988474)  2026-02-10T00:16Z [----] followers, [---] engagements


"1. KAIMRC [--]. XPRIZE Healthspan XPRIZE1RS5614 [--]. [----] [----] IR XPRIZE 2026TOP10 IR ✅ ✅ ✅ KAIMRC"  
[X Link](https://x.com/anyuser/status/2020766859914788920)  2026-02-09T07:48Z [---] followers, 22.9K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing